These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial. Amsterdam JD, Wang CH, Shwarz M, Shults J. J Affect Disord; 2009 Jan; 112(1-3):219-30. PubMed ID: 18486235 [Abstract] [Full Text] [Related]
3. [Antipsychotics in bipolar disorders]. Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L. Encephale; 2004 Jan; 30(5):417-24. PubMed ID: 15627046 [Abstract] [Full Text] [Related]
4. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study. Amsterdam JD, Lorenzo-Luaces L, Soeller I, Li SQ, Mao JJ, DeRubeis RJ. J Affect Disord; 2015 Oct 01; 185():31-7. PubMed ID: 26143402 [Abstract] [Full Text] [Related]
5. Rapid versus non-rapid cycling bipolar II depression: response to venlafaxine and lithium and hypomanic risk. Lorenzo-Luaces L, Amsterdam JD, Soeller I, DeRubeis RJ. Acta Psychiatr Scand; 2016 Jun 01; 133(6):459-69. PubMed ID: 26803764 [Abstract] [Full Text] [Related]
6. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU. Eur Neuropsychopharmacol; 2008 Jul 01; 18(7):535-49. PubMed ID: 18501566 [Abstract] [Full Text] [Related]
7. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety. Ghaemi SN, Ostacher MM, El-Mallakh RS, Borrelli D, Baldassano CF, Kelley ME, Filkowski MM, Hennen J, Sachs GS, Goodwin FK, Baldessarini RJ. J Clin Psychiatry; 2010 Apr 01; 71(4):372-80. PubMed ID: 20409444 [Abstract] [Full Text] [Related]
8. Bipolar II disorder : epidemiology, diagnosis and management. Benazzi F. CNS Drugs; 2007 Apr 01; 21(9):727-40. PubMed ID: 17696573 [Abstract] [Full Text] [Related]
9. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS. Cerbo AD. Turk Psikiyatri Derg; 2021 Apr 01; 32(4):293-295. PubMed ID: 34964106 [Abstract] [Full Text] [Related]
10. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study. Hantouche EG, Akiskal HS, Lancrenon S, Chatenêt-Duchêne L. J Affect Disord; 2005 Feb 01; 84(2-3):243-9. PubMed ID: 15708422 [Abstract] [Full Text] [Related]
11. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence. Kemp DE, Gao K, Ganocy SJ, Elhaj O, Bilali SR, Conroy C, Findling RL, Calabrese JR. J Clin Psychiatry; 2009 Jan 01; 70(1):113-21. PubMed ID: 19192457 [Abstract] [Full Text] [Related]
12. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Leverich GS, Altshuler LL, Frye MA, Suppes T, McElroy SL, Keck PE, Kupka RW, Denicoff KD, Nolen WA, Grunze H, Martinez MI, Post RM. Am J Psychiatry; 2006 Feb 01; 163(2):232-9. PubMed ID: 16449476 [Abstract] [Full Text] [Related]
13. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study. Amsterdam JD, Shults J. J Clin Psychopharmacol; 2008 Apr 01; 28(2):171-81. PubMed ID: 18344727 [Abstract] [Full Text] [Related]
14. Depression with versus without manic features in rapid-cycling bipolar disorder. Goldberg JF, Wankmuller MM, Sutherland KH. J Nerv Ment Dis; 2004 Sep 01; 192(9):602-6. PubMed ID: 15348976 [Abstract] [Full Text] [Related]
15. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study. Altshuler LL, Post RM, Hellemann G, Leverich GS, Nolen WA, Frye MA, Keck PE, Kupka RW, Grunze H, McElroy SL, Sugar CA, Suppes T. J Clin Psychiatry; 2009 Apr 01; 70(4):450-7. PubMed ID: 19358785 [Abstract] [Full Text] [Related]
16. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Kupka RW, Luckenbaugh DA, Post RM, Suppes T, Altshuler LL, Keck PE, Frye MA, Denicoff KD, Grunze H, Leverich GS, McElroy SL, Walden J, Nolen WA. Am J Psychiatry; 2005 Jul 01; 162(7):1273-80. PubMed ID: 15994709 [Abstract] [Full Text] [Related]
18. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J, Lamictal 605 Study Group. J Clin Psychiatry; 2003 Sep 01; 64(9):1013-24. PubMed ID: 14628976 [Abstract] [Full Text] [Related]
19. Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients. Koukopoulos A, Sani G, Koukopoulos AE, Minnai GP, Girardi P, Pani L, Albert MJ, Reginaldi D. J Affect Disord; 2003 Jan 01; 73(1-2):75-85. PubMed ID: 12507740 [Abstract] [Full Text] [Related]
20. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Gao K, Kemp DE, Ganocy SJ, Muzina DJ, Xia G, Findling RL, Calabrese JR. Bipolar Disord; 2008 Dec 01; 10(8):907-15. PubMed ID: 19594506 [Abstract] [Full Text] [Related] Page: [Next] [New Search]